Andere talen Prestige Consumer Healthcare Inc.

Aandelen

PBH

US74112D1019

Geschatte realtime Cboe BZX Andere beurzen 19:12:49 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
69,1 ^USD	+1,10%		+1,25%	+12,84%

16/02	Insider bij Prestige Consumer Healthcare verkocht aandelen ter waarde van $1.766.665, volgens een recent SEC-document	MT
16/02	Insider bij Prestige Consumer Healthcare verkocht aandelen ter waarde van $2.051.874, volgens een recent SEC-document	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag	03/04
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation	07/03
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing	16/02
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing	16/02
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing	12/02
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain	08/02
North American Morning Briefing : S&P 500 to Open -2-	08/02
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 Revenue $282.7M, vs. Street Est of $280.4M	08/02
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 EPS $1.06, vs. Street Est of $1.04	08/02
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot	08/02
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results	08/02
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024	08/02
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene	02/02
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene	22/12
Prestige Consumer Healthcare Unit Recalls One Lot of Anesthetic Spray Due to Benzene Presence	22/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Prestige Consumer Healthcare Inc.

Aandelen

PBH

US74112D1019

Andere talen

Filters